Compare YDES & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | YDES | TIPT |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | Taiwan | United States |
| Employees | N/A | 1486 |
| Industry | | Property-Casualty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 634.8M |
| IPO Year | N/A | 2017 |
| Metric | YDES | TIPT |
|---|---|---|
| Price | $7.43 | $16.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.2K | ★ 260.6K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.76 |
| Revenue | N/A | ★ $488,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.40 | $15.49 |
| 52 Week High | $25.00 | $27.38 |
| Indicator | YDES | TIPT |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 52.28 |
| Support Level | N/A | $16.41 |
| Resistance Level | $9.11 | $18.15 |
| Average True Range (ATR) | 0.87 | 0.33 |
| MACD | 0.18 | 0.11 |
| Stochastic Oscillator | 60.24 | 80.89 |
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.